175 related articles for article (PubMed ID: 2705790)
1. [Expression of cell surface transformation-associated antigens TAAs on activated oncogene-transfected rat fibroblast and antitumor immunity by hosts].
Sato N; Yagihashi A; Konno A; Torigoe T; Kikuchi K
Gan To Kagaku Ryoho; 1989 Mar; 16(3 Pt 2):653-61. PubMed ID: 2705790
[TBL] [Abstract][Full Text] [Related]
2. Identification of the transformation-associated cell surface antigen expressed on the rat fetus-derived fibroblast.
Yagihashi A; Sato N; Torigoe T; Okubo M; Konno A; Takahashi N; Yamashita T; Fujinaga K; Kuzumaki N; Kikuchi K
Cancer Res; 1988 May; 48(10):2798-804. PubMed ID: 3162824
[TBL] [Abstract][Full Text] [Related]
3. Heat- or stress-inducible transformation-associated cell surface antigen on the activated H-ras oncogene-transfected rat fibroblast.
Konno A; Sato N; Yagihashi A; Torigoe T; Cho JM; Torimoto K; Hara I; Wada Y; Okubo M; Takahashi N
Cancer Res; 1989 Dec; 49(23):6578-82. PubMed ID: 2555046
[TBL] [Abstract][Full Text] [Related]
4. Natural killer target molecules associated with the transformation of the oncogene-transfected fibroblast.
Cho JM; Sato N; Yagihashi A; Konno A; Hara I; Konn S; Torigoe T; Qi W; Takashima T; Takahashi N
Cancer Res; 1991 Aug; 51(16):4250-6. PubMed ID: 1868445
[TBL] [Abstract][Full Text] [Related]
5. 70 kDa heat shock cognate protein is a transformation-associated antigen and a possible target for the host's anti-tumor immunity.
Tamura Y; Tsuboi N; Sato N; Kikuchi K
J Immunol; 1993 Nov; 151(10):5516-24. PubMed ID: 8228242
[TBL] [Abstract][Full Text] [Related]
6. Involvement of peptide antigens in the cytotoxicity between 70-kDa heat shock cognate protein-like molecule and CD3+, CD4-, CD8-, TCR-alpha beta- killer T cells.
Takashima S; Sato N; Kishi A; Tamura Y; Hirai I; Torigoe T; Yagihashi A; Takahashi S; Sagae S; Kudo R; Kikuchi K
J Immunol; 1996 Oct; 157(8):3391-5. PubMed ID: 8871636
[TBL] [Abstract][Full Text] [Related]
7. The expression of tumor rejection antigen on rat fetus fibroblasts transformed by the ras oncogene.
Okubo M; Yagihashi A; Torigoe T; Konno A; Sato N; Kikuchi K
Jpn J Cancer Res; 1988 Jul; 79(7):850-6. PubMed ID: 3139598
[TBL] [Abstract][Full Text] [Related]
8. Enhanced lytic susceptibility of Ha-ras transformants after oncogene induction is specific to activated NK cells.
Johnson PW; Trimble WS; Hozumi N; Roder JC
J Immunol; 1987 Jun; 138(11):3996-4003. PubMed ID: 3495578
[TBL] [Abstract][Full Text] [Related]
9. Tumor rejection antigens on BALB3T3 cells transformed by activated oncogenes.
Torigoe T; Sato N; Takashima T; Cho JM; Tsuboi N; Qi WM; Hara I; Wada Y; Takahashi N; Kikuchi K
J Immunol; 1991 Nov; 147(9):3251-8. PubMed ID: 1919013
[TBL] [Abstract][Full Text] [Related]
10. Immunogenicity and involvement in the host's effector mechanisms of the oncogene--induced transformation--associated cell surface antigens.
Sato N; Cho JM; Takashima T; Tsuboi N; Nihei T; Wada Y; Kikuchi K
In Vivo; 1991; 5(6):663-70. PubMed ID: 1810453
[TBL] [Abstract][Full Text] [Related]
11. Interleukin-10 reduces natural killer sensitivity and downregulates MHC class I expression on H-ras-transformed cells.
Tsuruma T; Yagihashi A; Torigoe T; Sato N; Kikuchi K; Watanabe N; Hirata K
Cell Immunol; 1998 Mar; 184(2):121-8. PubMed ID: 9630838
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of natural killer cell cytotoxicity by cell growth-related molecules.
Tamura Y; Takashima S; Cho JM; Qi W; Kamiguchi K; Torigoe T; Takahashi S; Hirai I; Sato N; Kikuchi K
Jpn J Cancer Res; 1996 Jun; 87(6):623-30. PubMed ID: 8766527
[TBL] [Abstract][Full Text] [Related]
13. Interleukin-10 inhibited the expression of tumor antigens and major histocompatibility complex antigen on EJ-ras oncogene transformants.
Tsuruma T; Yagihashi A; Torigoe T; Okada Y; Sato N; Kikuchi K; Hirata K
Artif Organs; 1996 Aug; 20(8):895-7. PubMed ID: 8853802
[TBL] [Abstract][Full Text] [Related]
14. Expression of hepatocyte and oval cell antigens in hepatocellular carcinomas produced by oncogene-transfected liver epithelial cells.
Goyette M; Faris R; Braun L; Hixson D; Fausto N
Cancer Res; 1990 Aug; 50(15):4809-17. PubMed ID: 2196118
[TBL] [Abstract][Full Text] [Related]
15. Suppression of MHC class I antigens in oncogenic transformants: association with decreased recognition by cytotoxic T lymphocytes.
Seliger B; Harders C; Wollscheid U; Staege MS; Reske-Kunz AB; Huber C
Exp Hematol; 1996 Sep; 24(11):1275-9. PubMed ID: 8862437
[TBL] [Abstract][Full Text] [Related]
16. Invasiveness and metastatic capability of rat fibroblast-like cells before and after transfection with immortalizing and transforming genes.
Van Roy FM; Messiaen L; Liebaut G; Gao J; Dragonetti CH; Fiers WC; Mareel MM
Cancer Res; 1986 Sep; 46(9):4787-95. PubMed ID: 3015398
[TBL] [Abstract][Full Text] [Related]
17. Cooperation between the H-ras oncogene and a truncated derivative of the v-myb oncogene in transformation of hamster embryo fibroblasts.
Merzak A; Dooghe Y; Pironin M; Perbal B; Vigier P
Oncogene; 1992 Oct; 7(10):2031-9. PubMed ID: 1408144
[TBL] [Abstract][Full Text] [Related]
18. Interleukin-10 reduces natural killer (NK) sensitivity of tumor cells by downregulating NK target structure expression.
Tsuruma T; Yagihashi A; Hirata K; Torigoe T; Araya J; Watanabe N; Sato N
Cell Immunol; 1999 Dec; 198(2):103-10. PubMed ID: 10648124
[TBL] [Abstract][Full Text] [Related]
19. A novel approach to production of antitumor monoclonal antibodies: antibody to a cell surface glycoprotein associated with transformation by a human oncogene.
Roth JA; Scuderi P; Westin E; Gallo RC
Surgery; 1984 Aug; 96(2):264-72. PubMed ID: 6379959
[TBL] [Abstract][Full Text] [Related]
20. Acquisition of a tumorigenic phenotype by a rat ventral prostate epithelial cell line expressing a transfected activated neu oncogene.
Sikes RA; Chung LW
Cancer Res; 1992 Jun; 52(11):3174-81. PubMed ID: 1350510
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
